ASCO 2025

pendulum silver metallic spheres on coloured background with drop shadow
Biotech

As investors pivot from cell therapy, Immatics keeps the faith

The biotech is planning for a potential commercial launch in the third quarter of 2027, a market debut Immatics intends to fund on its own.
Gabrielle Masson Jun 6, 2025 3:50am
photo of a pair of binoculars perched on a rock aimed at the rising sun

Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in

Jun 4, 2025 1:00pm
blood test vials

Guardant360-guided breast cancer therapy swaps boost survival

Jun 3, 2025 10:00am
medical data concept with hospital in the background

OSE shares 65% OS rate behind cancer vaccine's phase 2 win

Jun 3, 2025 7:05am
cancer target detection radiopharma radio

ASCO: Kura, Kyowa reveal 23% remission rate behind leukemia win

Jun 2, 2025 5:36pm
race track

Bicara CEO: ASCO data resonate more with 'people that matter'

Jun 2, 2025 4:26pm